[1]方邦江齐文升任毅 周爽 陈晓蓉 曹敏邓跃毅郭建文 刘力7 刘婉嫣8廖成荣9李旭成0 石李 孙鼎宋娟9 叶勇 杨志旭 尹琴 伍宏泽 郑偕扣 郑月娟张文 张硕 张翔宇7.新冠肺炎奥密克戎变异株中成药应用专家共识[J].陕西中医药大学学报,2022,(06):001-7.[doi:10.13424/j.cnki.jsctcm.2022.06.001]
点击复制

新冠肺炎奥密克戎变异株中成药应用专家共识
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2022年06期
页码:
001-7
栏目:
出版日期:
2022-11-20

文章信息/Info

Title:
Expert Consensus on Application of Chinese Patent Medicine of COVID-19 Omicron Mutant
文章编号:
2096-1340(2022)06-0001-07
作者:
方邦江1齐文升2任毅3 周爽4 陈晓蓉5 曹敏1邓跃毅1郭建文6 刘力7 刘婉嫣8廖成荣9李旭成10 石李1 孙鼎1宋娟9 叶勇11 杨志旭12 尹琴13 伍宏泽14 郑偕扣15 郑月娟16张文1 张硕15 张翔宇17
1.上海中医药大学附属龙华医院;2.中国中医科学院广安门医院;3.重庆市中医医院;4上海中医药大学;5上海市公共卫生中心;6广东省中医院;7陕西中医药大学疫病研究院;8吉林市中西医结合医院;9重庆市垫江县中医院;10武汉市中医医院;11云南省中医医院;12中国中医科学院西苑医院;13湖北省中西医结合医院;14九江市中医医院;15天津中医药大学第二附属医院;16上海中医药大学;17同济大学附属第十人名医院;
关键词:
新型冠状病毒奥密克戎中医中成药专家共识
Keywords:
COVID-19OmikjonChinese medicineChinese patent medicineExpert consensus
分类号:
R286
DOI:
10.13424/j.cnki.jsctcm.2022.06.001
文献标志码:
A
摘要:
新冠肺炎自2020年爆发以来,中医药取得举世瞩目的救治效果,在全球疫情防控中发挥着重要作用,获得了WHO的高度肯定。2021年11月新冠肺炎奥密克戎(Omicron)变异株首次出现并迅速传播,我国吉林、上海先后出现爆发并蔓延全国。为了更加有效应对奥密克戎变异株感染,世界中医药学会联合会急症专业委员会、中华医学会急诊分会中西医结合急救学组、中国医师协会急诊医师分会中西医结合急救医学学组、上海中医药学会急诊分会、上海中医药大学急危重研究所等学术机构组织奥密克戎新冠肺炎变异株一线救治专家,根据上海、吉林等奥密克戎感染地区患者中医临床症候,并结合国家《新型冠状病毒诊疗方案(试行第九版)》,就中成药应用相关问题展开调研与讨论,形成本共识,以期对当下新冠肺炎奥密克戎变异株感染乃至以后疫情防控起到临床指导作用。
Abstract:
Since the outbreak of COVID-19 in 2020,Chinese medicine has achieved remarkable treatment results,played an important role in the global epidemic prevention and control,and was highly recognized by WHO.In November 2021,the COVID-19 Omicron mutant appeared for the first time and spread rapidly.Jilin and Shanghai in China successively broke out and spread throughout the country.In order to more effectively respond to the infection of Omikron’s variant strain,the World Federation of Chinese Medical Societies Emergency Committee,the First Aid Group of Integrated Traditional Chinese and Western Medicine of the Emergency Branch of the Chinese Medical Association,the First Aid Group of Integrated Traditional Chinese and Western Medicine of the Emergency Branch of the Emergency Physician Branch of the Chinese Medical Association,the Emergency Branch of the Shanghai Chinese Medical Association,the Institute of Emergency and Critical Care of the Shanghai University of Traditional Chinese Medicine and other academic institutions have organized first-line treatment experts for Omikron’s COVID-19 variant strain.The clinical symptoms of patients in Jilin and other areas infected with Omikron were investigated and discussed on issues related to the application of Chinese patent medicine in combination with the National Diagnosis and Treatment Plan forCOVID-19 (Trial Version 9),and a consensus was formed,with a view to playing a clinical guiding role in the prevention and control of the current infection of Omikron variant of COVID-19 and the future epidemic situation.

参考文献/References:

[1]中国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第九版)[J].国际流行病学传染病学杂志,2022,49(2):73-80.
[2]方邦江,苏红,赵软金,等.新型冠状病毒奥密克戎变异株感染中医药防治专家共识[J].中国急救医学,2022,42(4):277-280.
[3]徐湘茹,孙鼎,曹敏,等.上海市4264例无症状及轻型新冠病毒感染者临床特征及预后转归分析[J].中华危重病急救医学,2022,34(5):449-453.
[4]方邦江,邬鑫鑫,张文,等.基于中医疫病理论之“表里双解”截断扭转法治疗新冠肺炎的理论与实践[J].陕西中医药大学学报,2022,45(4):1-6.
[5]方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用[J].陕西中医药大学学报,2022,45(3):1-4.
[6]方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册[M].北京:人民卫生出版社,2020.
[7]陈晓蓉,方邦江.中西医结合诊疗新型冠状病毒肺炎验案120例[M].上海:上海科学技术出版社,2020.
[8]苗青,史利卿,封继宏,农英.中成药防治新型冠状病毒肺炎专家共识[J/OL].中国中西医结合杂志:1-4[2022-09-26].http://kns.cnki.net/kcms/detail/11.2787.R.20220301.1533.004.html
[9]北京中医药学会临床合理用药评价专业委员会,首都医科大学附属北京世纪坛医院临床合理用药生物特征谱学评价北京重点实验室.新型冠状病毒肺炎早期中成药干预的药学共识(北京)[J].中国医院药学杂志,2020,40(8):837-846.
[10]方邦江,张文,周爽,等.基于“急性虚证”理论防治新型冠状病毒肺炎探析[J].中医杂志,2021,62(9):826-828.
[11]上海市新型冠状病毒感染中医药诊疗专家共识(2022春季版)[J].上海中医药杂志,2022,56(7):5-6.
[12]田琳,王檀,王子元,等.2108例新型冠状病毒奥密克戎变异株感染患者的中医证候特征及诊疗策略探析[J].中华中医药学刊,2022,40(5):17-20.

相似文献/References:

[1]马战平,刘翠彤,刘莉君.中医方法诊治新型冠状病毒肺炎思路探微[J].陕西中医药大学学报,2020,(预出版):028.
 MaZhanping . LiuYitong LiuLIjun.TCM diagnosis and treatment 2019 - nCoV pneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(06):028.
[2]叶峥嵘 杨晓航.基于新型冠状病毒的《医学微生物学》课程思政探索[J].陕西中医药大学学报,2020,(5):098.[doi:10.13424/j.cnki.jsctcm.2020.05.024]
[3]马战平刘羿彤 刘莉君.中医方法诊治新型冠状病毒肺炎思路探微[J].陕西中医药大学学报,2020,(6):001.[doi:10.13424/j.cnki.jsctcm.2020.06.001]
 Ma Zhanping,LiuYitong,Liu Lijun.An Exploration of TCM Diagnosis and Treatment of Covid -19[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(06):001.[doi:10.13424/j.cnki.jsctcm.2020.06.001]
[4]陈扬,苏同生,伍洁洁.中药香囊在新型冠状病毒肺炎中的应用探讨[J].陕西中医药大学学报,2021,44(01):015.[doi:10.13424/j.cnki.jsctcm.2021.01.003]
 CHEN Yang,SU Tong - sheng,WU Jie - jie.Discussion on Application of Herbal Sachet in COVID-19[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(06):015.[doi:10.13424/j.cnki.jsctcm.2021.01.003]

备注/Memo

备注/Memo:
国家中医药管理局2022年第五批新型冠状病毒感染肺炎中医药应急专项课题(2022ZYLCYJ05-4);上海中医药大学2022年度应对奥密克戎感染新型冠状病毒肺炎应急攻关项目(2022YJ-03,2022YJ-06)
更新日期/Last Update: 2022-12-05